Ameriprise
CTSO icon

Ameriprise’s Cytosorbents Corp CTSO Stock Holding History

Ameriprise’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-101,645
Closed -$222K – 3967
2022
Q2 		$222K Sell
101,645
-1,092
-1% -$2.51K ﹤0.01% 3660
2022
Q1 		$327K Buy
102,737
+2,326
+2% +$8.33K ﹤0.01% 3614
2021
Q4 		$421K Buy
100,411
+43,933
+78% +$246K ﹤0.01% 3572
2021
Q3 		$459K Sell
56,478
-23,445
-29% -$190K ﹤0.01% 3432
2021
Q2 		$604K Sell
79,923
-2,109
-3% -$17.8K ﹤0.01% 3389
2021
Q1 		$712K Buy
82,032
+43,842
+115% +$418K ﹤0.01% 3280
2020
Q4 		$305K Buy
+38,190
New +$320K ﹤0.01% 3499

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Ameriprise's CTSO Position: Q3 2022 in Review

Ameriprise sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 101,645 shares — an estimated $222K sold.

Ameriprise first reported a position in CTSO in Q4 2020 and held it in 7 quarters. The position peaked at $712K in Q1 2021. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Ameriprise reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 101,645 Cytosorbents Corp shares in Q3 2022, an estimated $222K.
  • Ameriprise first reported a position in Cytosorbents Corp in Q4 2020 and held it in 7 quarters.
  • Ameriprise's Cytosorbents Corp position peaked at $712K in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.